Can Asthma Flare-Ups Increase Fasting Blood Glucose?
Yes, asthma exacerbations can significantly increase fasting blood glucose levels, primarily through the medications used to treat them (especially systemic corticosteroids and beta-2 agonists) and through the physiological stress response, though the exacerbation itself may contribute through inflammatory pathways.
Primary Mechanisms of Hyperglycemia During Asthma Exacerbations
Medication-Induced Hyperglycemia
The most clinically significant cause of elevated blood glucose during asthma flare-ups is systemic corticosteroid therapy, which is the cornerstone of treatment for moderate to severe exacerbations 1. These medications have potent hyperglycemic effects that frequently lead to loss of glycemic control in patients with pre-existing diabetes or can unmask previously undiagnosed diabetes 2.
Beta-2 agonists (like albuterol/salbutamol) also contribute to hyperglycemia, particularly when administered in the frequent high doses typical during acute exacerbations 3. This effect occurs even with nebulized administration in children and adults.
Prevalence and Clinical Impact
The magnitude of this problem is substantial:
- 82% of hospitalized patients with asthma or COPD exacerbations demonstrate hyperglycemia, even among those without a previous diabetes diagnosis (79% of non-diabetics showed hyperglycemia) 4
- In children hospitalized with acute asthma, 38.6% developed hyperglycemia (defined as blood glucose ≥11.1 mmol/L) 5
- Hyperglycemia during asthma exacerbations is associated with significantly longer hospitalization times regardless of insulin therapy approach 2, 5
Physiological Stress and Inflammatory Pathways
Beyond medication effects, the exacerbation itself contributes through:
- Acute stress response with catecholamine and cortisol release
- Systemic inflammation with elevated C-reactive protein correlating with hyperglycemia 4
- Metabolic predisposition being the primary determinant of who develops hyperglycemia, with high baseline HbA1c being the strongest predictor 4
The bidirectional relationship is important: poor glycemic control can worsen asthma outcomes, increase exacerbations, and reduce lung function 6, 7. This creates a potential vicious cycle where asthma exacerbations raise glucose, and elevated glucose worsens asthma control.
Clinical Predictors of Hyperglycemia
Key factors associated with hyperglycemia during exacerbations include 4:
- High baseline HbA1c (strongest predictor)
- Elevated C-reactive protein
- Karnofsky performance score <80%
- Current smoking status
Clinical Management Implications
Monitor blood glucose closely in all patients hospitalized for asthma exacerbations, regardless of diabetes history. The hyperglycemia typically resolves spontaneously after the acute phase and medication tapering 5, but during the exacerbation:
- Expect glucose elevations with standard treatment (systemic corticosteroids for 3-10 days per guidelines 1)
- Consider that hyperglycemia serves as a marker for more severe illness and longer hospital stays
- In patients with diabetes, anticipate need for intensified glucose management during the 3-10 day corticosteroid course
Important Caveats
The hyperglycemia is primarily iatrogenic and stress-related rather than a direct pathophysiological effect of bronchospasm itself. The asthma exacerbation creates the clinical scenario requiring medications that cause hyperglycemia, combined with acute physiological stress. This distinction matters because the glucose elevation is expected and typically transient, resolving with treatment completion rather than requiring long-term diabetes management changes in most cases.
Interestingly, certain diabetes medications—particularly metformin and GLP-1 receptor agonists—may actually reduce asthma exacerbation rates through anti-inflammatory mechanisms independent of glycemic control 8, suggesting potential therapeutic opportunities in patients with both conditions.